Angiotensin-Converting Enzyme Inhibitors in Black Patients
Authors: Lizzy M. Brewster, Gert A. van Montfrans, Jos Kleijnen
Journal: Annals of Internal Medicine (2005)

Letters5 April 2005Angiotensin-Converting Enzyme Inhibitors in Black PatientsLizzy M. Brewster, MD, Gert A. van Montfrans, MD, PhD, and Jos Kleijnen, MD, PhDLizzy M. Brewster, MDFrom Academic Medical Center, 1105 AZ, Amsterdam, the Netherlands, and University of York, York YO10 5DD, United Kingdom.Search for more papers by this author, Gert A. van Montfrans, MD, PhDFrom Academic Medical Center, 1105 AZ, Amsterdam, the Netherlands, and University of York, York YO10 5DD, United Kingdom.Search for more papers by this author, and Jos Kleijnen, MD, PhDFrom Academic Medical Center, 1105 AZ, Amsterdam, the Netherlands, and University of York, York YO10 5DD, United Kingdom.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-142-7-200504050-00018 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:We thank Drs. Kaufman and Flack for their careful reading of our paper and for their response. They raise an important issue regarding separate consideration of hypertensive black persons when discussing treatment (1). Although there is overlap in response with other population groups, there are differences as well, and there is clearly no consensus on this matter. As a result, different national and international guidelines offer the clinician different advice on treatment of black patients.The comments by Drs. Kaufman and Flack allow us to reemphasize the purpose of our systematic review, which was to establish, for the ...References1. Cooper RS, Kaufman JS, Ward R. Race and genomics. N Engl J Med. 2003;348:1166-70. [PMID: 12646675] CrossrefMedlineGoogle Scholar2. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199-206. [PMID: 12851274] CrossrefMedlineGoogle Scholar3. Ayala C, Croft JB, Wattigney WA, Mensah GA. Trends in hypertension-related death in the United States: 1980-1998. J Clin Hypertens Greenwich. 2004;6:675-81. [PMID: 15599115] CrossrefMedlineGoogle Scholar4. Brewster LM, Kleijnen J, van Montfrans GA. Pharmacotherapy for hypertension in people of sub-Saharan Africa or of sub-Saharan African descent. The Cochrane Library. Oxford: Update Software; 2001. Google Scholar Author, Article, and Disclosure InformationAffiliations: From Academic Medical Center, 1105 AZ, Amsterdam, the Netherlands, and University of York, York YO10 5DD, United Kingdom. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoSystematic Review: Antihypertensive Drug Therapy in Black Patients Lizzy M. Brewster , Gert A. van Montfrans , and Jos Kleijnen Angiotensin-Converting Enzyme Inhibitors in Black Patients Jay S. Kaufman and John M. Flack Metrics 5 April 2005Volume 142, Issue 7Page: 589-590KeywordsACE inhibitorsBlood pressureDrugsForecastingHypertensionMyocardial infarctionPatientsSystematic reviewsTreatment guidelines ePublished: 5 April 2005 Issue Published: 5 April 2005 CopyrightCopyright © 2005 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...